Role of adipose specific lipid droplet proteins in maintaining whole body energy homeostasis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 3, 2014, Pages 393-401

  Konige, Manige ^a   Wang, Hong ^a   Sztalryd, Carole ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Adipose tissue; Insulin resistance; Lipid droplet associated protein; Lipid droplet growth; Obesity

Indexed keywords

CAVEOLIN; FAT DROPLET; LIPID DROPLET PROTEIN; PERILIPIN; PROTEOME; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; ENERGY BALANCE; HUMAN; HYDROLYSIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIPOTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; INSULIN RESISTANCE; LIPID DROPLET ASSOCIATED PROTEIN; LIPID DROPLET GROWTH; OBESITY;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; OBESITY; PHOSPHOPROTEINS;

EID: 84893703067     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.05.007     Document Type: Review

References (106)

1. Walther T.C., Farese R.V. Lipid droplets and cellular lipid metabolism. Annu. Rev. Biochem. 2012, 81:687-714.
2. Brasaemle D.L., Wolins N.E. Packaging of fat: an evolving model of lipid droplet assembly and expansion. J. Biol. Chem. 2012, 287(4):2273-2279.
3. Mak H.Y. Lipid droplets as fat storage organelles in Caenorhabditis elegans: thematic review series: lipid droplet synthesis and metabolism: from yeast to man. J. Lipid Res. 2012, 53:28-33.
4. Murphy D.J. The dynamic roles of intracellular lipid droplets: from archaea to mammals. Protoplasma 2012, 249:541-585.
5. Suzuki M., Shinohara Y., Ohsaki Y., Fujimoto T. Lipid droplets: size matters. J. Electron Microsc. (Tokyo) 2011, 60(Suppl. 1):S101-S116.
6. Fujimoto T., Parton R.G. Not just fat: the structure and function of the lipid droplet. Cold Spring Harb. Perspect. Biol. 2011, 3.
7. Greenberg A.S., Coleman R.A., Kraemer F.B., McManaman J.L., Obin M.S., Puri V., Yan Q.W., Miyoshi H., Mashek D.G. The role of lipid droplets in metabolic disease in rodents and humans. J. Clin. Invest. 2011, 121:2102-2110.
8. Le Lay S., Dugail I. Connecting lipid droplet biology and the metabolic syndrome. Prog. Lipid Res. 2009, 48:191-195.
9. Karpe F., Dickmann J.R., Frayn K.N. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011, 60:2441-2449.
10. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. J. Clin. Invest. 2011, 121:2094-2101.
11. Lee M.J., Wu Y., Fried S.K. Adipose tissue remodeling in pathophysiology of obesity. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:371-376.
12. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., Schraw T., Durand J.L., Li H., Li G., Jelicks L.A., Mehler M.F., Hui D.Y., Deshaies Y., Shulman G.I., Schwartz G.J., Scherer P.E. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 2007, 117:2621-2637.
13. Khan T., Muise E.S., Iyengar P., Wang Z.V., Chandalia M., Abate N., Zhang B.B., Bonaldo P., Chua S., Scherer P.E. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 2009, 6:1575-1591.
14. McLaughlin T., Sherman A., Tsao P., Gonzalez O., Lamendola C., Reaven G.M., Cushman S.W. Enhanced proportion of small adipose cells in insulin-resistant vs. insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007, 50:1707-1715.
15. Rosen E.D., Sarraf P., Troy E., Bradwin G., Moore K., Milstone D.S., Speigelman B.M., Mortensen R.M. PPARgamma is required for the differentiation of adipose tissue in vivo and invitro. Mol. Cell 1999, 4:611-617.
16. Reaven G.M. Insulin resistance: the link between obesity and cardiovascular disease. Med. Clin. North Am. 2011, 95:875-892.
17. Opie L.H., Walfish P.G. Plasma free fatty acid concentrations in obesity. N. Engl. J. Med. 1963, 26:757-760.
18. Boden G., Chen X., Ruiz J., White J.V., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 1994, 93:2438-2446.
19. Unger R.H., Clark G.O., Scherer P.E., Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 2010, 1801:209-214.
20. Romeo G.R., Lee J., Shoelson S.E. Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1771-1776.
21. Vigouroux C., Caron-Debarle M., Le Dour C., Magré J., Capeau J. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int. J. Biochem. Cell Biol. 2011, 43:862-876.
22. Garg A. Clinical review#: lipodystrophies: genetic and acquired body fat disorders. J. Clin. Endocrinol. Metab. 2011, 96:3313-3325.
23. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., Kuo F.C., Palmer E.L., Tseng Y.H., Doria A., Kolodny G.M., Kahn C.R. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360:1500-1508.
24. Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., Schrauwen P., Teule G.J. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 2009, 360:1509-1517.
25. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., Taittonene M., Laine J., Savisto N.J., Enerbach S., Nuutila P. Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 2009, 360:1518-1525.
26. Zingaretti M.C., Crosta F., Vitali A., Guerrieri M., Frontini A., Cannon B., Nedergaard J., Cinti S. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J. 2009, 23:3113-3120.
27. Saito M., Okamatsu-Ogura Y., Matsushita M., Watanabe K., Yoneshiro T., Kobayashi J., Iwanaga T., Myagawa M., Kameya T., Nakada K., Kawai Y., Tsujisaki M. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 2009, 58:1526-1531.
28. Smorlesi A., Frontini A., Giordano A., Cinti S. The adipose organ: white-brown adipocyte plasticity and metabolic inflammation. Obes. Rev. 2012, 13:83-96.
29. Almind K., Manieri M., Sivitz W.I., Cinti S., Kahn C.R. Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2366-2371.
30. Wu J., Cohen P., Spiegelman B.M. Adaptive thermogenesis in adipocytes: is beige the new brown?. Genes Dev. 2013, 27:234-250.
31. Barbatelli G., Murano I., Madsen L., Hao Q., Jimenez M., Kristiansen K., Giacobino J.P., De Matteis R., Cinti S. The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E1244-E1253.
32. Petrovic N., Walden T.B., Shabalina I.G., Timmons J.A., Cannon B., Nedergaard J. Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J. Biol. Chem. 2010, 285:7153-7164.
33. Cannon, Nedergaard J. Brown adipose tissue, function and physiological significance. Physiol. Rev. 2004, 84:277-359.
34. Wolf G. Brown adipose tissue: the molecular mechanism of its formation. Nutr. Rev. 2009, 67:167-171.
35. Greenberg A.S., Egan J.J., Wek S.A., Garty N.B., Blanchette-Mackie E.J., Londos C. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J. Biol. Chem. 1991, 266:11341-11346.
36. Beller M., Thiel K., Thul P.J., Jäckle H. Lipid droplets: a dynamic organelle moves into focus. FEBS Lett. 2010, 584:2176-2182.
37. Beller M., Sztalryd C., Southall N., Bell M., Jäckle H., Auld D.S., Oliver B. COPI complex is a regulator of lipid homeostasis. PLoS Biol. 2008, 6:e292.
38. Zehmer J.K., Huang Y., Peng G., Pu J., Anderson R.G., Liu P. A role for lipid droplets in inter-membrane lipid traffic. Proteomics 2009, 9:914-921.
39. Guo Y., Walther T.C., Rao M., Stuurman N., Goshima G., Terayama K., Wong J.S., Vale R.D., Walter P., Farese R.V. Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature 2008, 453:657-661.
40. Prattes S., Horl G., Hammer A., Blaschitz A., Graier W.F., Sattler W., Zechner R., Steyrer E. Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures. J. Cell Sci. 2000, 113:2977-2989.
41. Brasaemle D.L., Dolios G., Shapiro L., Wang R. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J. Biol. Chem. 2004, 279:46835-46837.
42. Ding Y., Wu Y., Zeng R., Liao K. Proteomic profiling of lipid droplet-associated proteins in primary adipocytes of normal and obese mouse. Acta Biochim. Biophys. 2012, 44:394-406.
43. Blouin C.M., Le Lay S., Eberl A., Köfeler H.C., Guerrera I.C., Klein C., Le Liepvre X., Lasnier F., Bourron O., Gautier J.F., Ferré P., Hajduch E., Dugail I. Lipid droplet analysis in caveolin-deficient adipocytes: alterations in surface phospholipid composition and maturation defects. J. Lipid Res. 2010, 51:945-956.
44. Cho S.Y., Shin E.S., Park P.J., Shin D.W., Chang H.K., Kim D., Lee H.H., Lee J.H., Kim S.H., Song M.J., Chang I.S., Lee O.S., Lee T.R. Identification of mouse Prp19p as a lipid droplet-associated protein and its possible involvement in the biogenesis of lipid droplets. J. Biol. Chem. 2007, 282:2456-2465.
45. Bickel P.E., Tansey J.T., Welte M.A. PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim. Biophys. Acta 2009, 1791:419-440.
46. Londos D., Sztalryd C., Tansey J.T., Kimmel A.R. Role of PAT proteins in lipid metabolism. Biochimie 2005, 87:45-49.
47. Brasaemle D.L. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 2007, 48:2547-2559.
48. Wang H., Sztalryd C. Oxidative tissue: perilipin 5 links storage with the furnace. Trends Endocrinol. Metab. 2011, 22:197-203.
49. Hsieh K., Lee Y.K., Londos C., Raaka B.M., Dalen K.T., Kimmel A.R. Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-ester-specific intracellular lipid storage droplets. J. Cell Sci. 2012, 125:4067-4076.
50. Akter M.H., Yamaguchi T., Hirose F., Osumi T. Perilipin, a critical regulator of fat storage and breakdown, is a target gene of estrogen receptor-related receptor alpha. Biochem. Biophys. Res. Com. 2008, 368:563-568.
51. Arimura N., Horiba T., Imagawa M., Shimizu M., Sato R. The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes. J. Biol. Chem. 2004, 279:10070-10076.
52. Dalen K.T., Schoonjans K., Ulven S.M., Weedon-Fekjaer M.S., Bentzen T.G., Koutnikova H., Auwerx J., Nebb H.I. Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-gamma. Diabetes 2004, 53:1243-1252.
53. Stenson B.M., Rydén M., Venteclef N., Dahlman I., Pettersson A.M., Mairal A., Aström G., Blomqvist L., Wang V., Jocken J.W., Clément K., Langin D., Arner P., Laurencikiene J. Liver X receptor (LXR) regulates human adipocyte lipolysis. J. Biol. Chem. 2011, 286:370-379.
54. Brasaemle D.L., Rubin B., Harten I.A., Gruia-Gray J., Kimmel A.R., Londos C. Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J. Biol. Chem. 2000, 275:38486-38493.
55. Miyoshi H., Souza S.C., Zhang H.H., Strissel K.J., Christoffolete M.A., Kovsan J., Rudich A., Kraemer F.B., Bianco A.C., Obin M.S., Greenberg A.S. Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J. Biol. Chem. 2006, 281:15837-15844.
56. Granneman J.G., Moore H.P., Krishnamoorthy R., Rathod M. Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl). J. Biol. Chem. 2009, 284:34538-34544.
57. Tansey J.T., Huml A.M., Vogt R., Davis K.E., Jones J.M., Fraser K.A., Brasaemle D.L., Kimmel A.R., Londos C. Functional studies on native and mutated forms of perilipins. A role in protein kinase A-mediated lipolysis of triacylglycerols. J. Biol. Chem. 2003, 278:8401-8406.
58. Wang H., Hu L., Dalen K., Dorward H., Marcinkiewicz A., Russell D., Gong D., Londos C., Yamaguchi T., Holm C., Rizzo M.A., Brasaemle D., Sztalryd C. Activation of hormone-sensitive lipase requires two steps, protein phosphorylation and binding to the PAT-1 domain of lipid droplet coat proteins. J. Biol. Chem. 2009, 284:32116-32125.
59. Lass A., Zimmermann R., Oberer M., Zechner R. Lipolysis-a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog. Lipid Res. 2011, 50:14-27.
60. Granneman J.G., Moore H.P. Location, location: protein trafficking and lipolysis in adipocytes. Trends Endocrinol. Metab. 2008, 19:3-9.
61. Shen W.J., Patel S., Mioshi H., Greenberg A.S., Kraemer F.B. Functional interaction of hormone sensitive lipase and perilipin in lipolysis. J. Lipid Res. 2009, 50.
62. Granneman J.G., More H.P., Krishnamoorhy R., Rahtod M. Perilipin control lipolysis by regulating the interactions of AB-hydrolase containing5 (Abhd5) and adipose triglyceride lipase (Atgl). J. Biol. Chem. 2009, 284:34538-34544.
63. Gandotra S., Lim K., Girousse A., Saudek V., O'Rahilly S., Savage D.B. Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5). J. Biol. Chem. 2011, 286:34998-35006.
64. Martinez-Botas J., Anderson J.B., Tessier D., Lapillonne A., Chang B.H., Quast M.J., Gorenstein D., Chen K.H., Chan L. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat. Genet. 2000, 26:474-479.
65. Tansey J.T., Sztalryd C., Gruia-Gray J., Roush D.L., Zee J.V., Gavrilova O., Reitman M.L., Deng C.X., Li C., Kimmel A.R., Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:6494-6499.
66. Saha P.K., Kojima H., Martinez-Botas J., Sunehag A.L., Chan L. Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J. Biol. Chem. 2004, 279:35150-35158.
67. Gandotra S., Le Dour C., Bottomley W., Cervera P., Giral P., Reznik Y., Charpentier G., Auclair M., Delépine M., Barroso I., Semple R.K., Lathrop M., Lascols O., Capeau J., O'Rahilly S., Magré J., Savage D.B., Vigouroux C. Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 2011, 364:740-748.
68. Kern P.A., Di Gregorio G., Lu T., Rassouli N., Ranganathan G. Perilipin expression in human adipose tissue is elevated with obesity. J. Clin. Endocrinol. Metab. 2004, 89:1352-1358.
69. Mottagui-Tabar S., Ryden M., Lofgren P., Faulds G., Hoffstedt J., Brookes A.J., Andersson I., Arner P. Evidence for an important role of perilipin in the regulation of human adipocyte lipolysis. Diabetologia 2003, 46:789-797.
70. Puri V., Ranjit S., Konda S., Nicoloro S.M., Staubhaar J., Chawla A., Chouinard M., Lin C., Burkart A., Corvera S., Perugini R.A., Czech M.P. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7833-7838.
71. Smith C.E., Ordovás J.M. Update on perilipin polymorphisms and obesity. Nutr. Rev. 2012, 70:611-621.
72. Gong J., Sun Z., Li P. CIDE proteins and metabolic disorders. Curr. Opin. Lipidol. 2009, 20:121-126.
73. Xu L., Zhou L., Li P. CIDE proteins and lipid metabolism. Arterioscler. Vasc. Biol. 2012, 32:1094-1098.
74. Qi J., Gong J., Zhao T., Zhao j., Lam P., Ye J., Li J.Z., Wu J., Zhou H.M., Li P. Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue. EMBO J. 2008, 27:1537-1548.
75. Puri V., Konda S., Ranjit S., Aouadi M., Chawla A., Chakladar M., Czech M.P. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J. Biol. Chem. 2007, 282:34213-34218.
76. Gong J., Sun Z., Wu L., Xu W., Schieber N., Xu D., Shui G., Yang H., Parton R.G., Li P. Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites. J. Cell Biol. 2011, 195:953-963.
77. Jambunathan S., Yin J., Khan W., Tamori Y., Puri V. FSP27 promotes lipid droplet clustering and then fusion to regulate triglyceride accumulation. PLoS One 2011, 6.
78. Wang X., Zhang B., Xu D., Gao J., Wang L., Wang Z., Shan Y., Purification X.Yu. Crystallization and preliminary X-ray crystallographic analysis of the. CIDE-N domain of Fsp27. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2012, 68:1529-1533.
79. Yang X., Heckmann B.L., Zhang X., Smas C.M., Liu J. Distinct mechanisms regulate ATGL-mediated adipocyte lipolysis by lipid droplet coat proteins. Mol. Endocrinol. 2013, 27:116-126.
80. Kulyte A., Pettersson A.T., Antoson P., Stenson B.M., Langib D., Gustafsson J.A., Staels B., Ryden M., Arner P., Laurencikiene J. CIDEA interacts with liver X receptors in white fat cells. FEBBS Lett. 2011, 585:744-748.
81. Wang W., Lv N., Zhang S., Shui G., Qian H., Zhang J., Chen Y., Ye J., Xie Y., Shen Y., Wenk M.R., Li P. Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids. Nat. Med. 2012, 18:235-243.
82. Ueno M., Shen W.J., Patel S., Greenberg A.S., Azhar S., Kraemer F.B. Fat specific protein 27 modulates nuclear factor of activated-T cells 5 and the cellular response to stress. J. Lipid Res. 2012, Epub ahead of print.
83. Nishino N., Tamori Y., Tateya S., Kawaguchi T., Shibakusa T., Mizunoya W., Inoue K., Kitazawa R., Kitazawa S., Matsuki Y., Hiramatsu R., Masubuchi S., Omachi A., Kimura K., Saito M., Amo T., Ohta S., Yamaguchi T., Osumi T., Cheng J., Fujimoto T., akao N.H., Nakao K., Aiba A., Okamura H., Fushiki T., Kasuga M. Fsp27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J. Clin. Invest. 2008, 118:2808-2821.
84. Toh S.Y., Gong J., Du G., Li J.Z., Yang S., Ye J., Yao H., Zhang Y., Xue B., Li Q., Yang H., Wen Z., Li P. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. PLoS One 2008, 3:e2890.
85. Zhou Z., Yon Toh S., Chen Z., Guo K., Ng C.P., Ponniah S., Lin S.C., Hong W., Li P. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat. Genet. 2003, 35:49-56.
86. Rubio-Cabezas O., Puri V., Murano I., Saudek V., Semple R.K., Dash S., Hyden C.S., Bottomley W., Vigouroux C., Magré J., Raymond-Barker P., Murgatroyd P.R., Chawla A., Skepper J.N., Chatterjee V.K., Suliman S., Patch A.M., Agarwal A.K., Garg A., Barroso I., Cinti S., Czech M.P., Argente J., O'Rahilly S., Savage D.B., LD Screening Consortium Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol. Med. 2009, 1:280-287.
87. Pilch P., Liu L. Fat caves: caveolae, lipid trafficking and lipid metabolism in adipocytes. Trends Endocrinol. Metab. 2011, 22:318-324.
88. Le Lay S., Blouin I.C.M., Hajduch E., Dugail I. Filling up adipocytes with lipids. Filling up adipocytes with lipids. Lesson from caveolin-1 deficiency 2009, 1791:514-518.
89. Briand N., Dugail I., Le Lay S. Cavin proteins: new players in the caveolae field. Biochimie 2011, 93:71-77.
90. Ost A., Ortegren U., Gustavsson J., Nystrom F.H., Strålfors P. Triacylglycerol is synthesized in a specific subclass of caveolae in primary adipocytes. J. Biol. Chem. 2005, 280:5-8.
91. Fujimoto H., Kogo K., Ishiguro K., Tauchi R., Nomura K. Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J. Cell Biol. 2001, 152:1079-1085.
92. Ostermeyer A.G., Paci J.M., Zeng Y., Lublin D.M., Munro S., Brown D.A. Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets. J. Cell Biol. 2001, 152:1071-1078.
93. Pol A., Luetterforst R., Lindsay M., Heino S., Ikonen E., Parton R.G. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J. Cell Biol. 2001, 152:1057-1070.
94. Cohen A.W., Razani B., Schubert W., Williams T.M., Wang X.B., Iyengar P., Brasaemle D.L., Scherer P.E., Lisanti M.P. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004, 53:1261-1270.
95. Storey S.M., McIntosh A.L., Senthivinayagam S., Moon K.C., Atshaves B.P. The phospholipid monolayer associated with perilipin-enriched lipid droplets is a highly organized rigid membrane structure. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E991-E1003.
96. Aboulaich N., Ortegren U., Vener A.V., Strålfors P. Association and insulin regulated translocation of hormone-sensitive lipase with PTRF. Biochem. Biophys. Res. Commun. 2006, 350:657-661.
97. Liu L., Brown D., McKee M., Lebrasseur N.K., Yang D., Albrecht K.H., Ravid K., Pilch P.F. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab. 2008, 8:310-317.
98. Kim C.A., Delepine M., Boutet E., Mourabit E.L., Le Lay S., Meier M., Nemani M., Bridel E., Leite C.C., Bertola D.R., Semple R.K., O'Rahilly S., Dugail I., Capeau J., Lathrop M., Magre J. Association of a homozygous non sense caveolin-1 mutation with beradinelli-seipin congenital lipodystrophy. J. Clin. Endocrinol. Metab. 2008, 93:1129-1134.
99. Cao H., Alston L., Ruschman J., Hegele R.A. Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia. Lipids Health Dis. 2008, 31:7,3.
100. Hayashi Y.K., Matsuda C., gawa O.M., Goto K., Tominaga K., Mitsuhashi S., Park Y.E., Nonaka I., Hino-Fukuyo N., Haginoya K., Sugano H., Nishino I. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J. Clin. Invest. 2009, 119:2623-2633.
101. Shastry S., Delgado M.R., Dirik E., Turkmen M., Agarwal A.K., Garg A. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am. J. Med. Genet. A 2010, 152A:2245-2253.
102. Hayer A., Stoeber M., Bissig C., Helenius A. Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes. Traffic 2010, 3:361-382.
103. Meshulam T., Breen M.R., Liu L., Parton R.G., Pilch P.F. Caveolins/caveolae protect adipocytes from fatty acid-mediated lipotoxicity 2011, 52:1526-1532.
104. Le Lay S., Briand N., Blouin C.M., Chateau D., Prado C., Lasnier F., Le Liepvre X., Hajduch E., Dugail I. The lipoatrophic caveolin-1 deficient mouse model reveals autophagy in mature adipocytes. Autophagy 2010, 6:754-763.
105. Briand N., Le Lay S., Sessa W.C., Ferré P., Dugail I. Distinct roles of endothelial and adipocyte caveolin-1 in macrophage infiltration and adipose tissue metabolic activity. Diabetes 2011, 60:448-453.
106. Reue K. A thematic review series: lipid droplet storage and metabolism: from yeast to man. J. Lipid Res. 2011, 52:1865-1868.